5 Mar 2026 · 3 min read
FDA GenAI clinical care regulation: why Breakthrough Device Designation matters
The FDA quietly granted Breakthrough Device Designation to a generative AI chatbot — not a diagnostic, not a scoring tool. An LLM that talks to post-surgical patients twice daily and escalates red flags. No GenAI device has ever received FDA authorization. This becomes the test case.